Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aspire Biopharma Holdings, Inc. - Common Stock (NQ:ASBP)

5.730 -0.240 (-4.02%)
Streaming Delayed Price Updated: 11:27 AM EDT, Jun 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aspire Biopharma Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Aspire Biopharma Issues Shareholder Letter
Via ACCESS Newswire
News headline image
Aspire Biopharma's BUZZ BOMBTM Partners with EoS Fitness to Empower High-Performance Lifestyles for Millions of Members
Via ACCESS Newswire
News headline image
MicroCap Stocks: GLE, ADMQ, ASBP, BRQL Gaining Attention Across AI Infrastructure, Aerospace, Biotech and Industrial Markets
Via AB Newswire
Topics Artificial Intelligence
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
Gapping stocks in Friday's session ↗
Via Chartmill
Which stocks are moving before the opening bell on Friday? ↗
Via Chartmill
These stocks are the most active in today's session ↗
Via Chartmill
News headline image
Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio
Via ACCESS Newswire
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
What's going on in today's after hours session ↗
Via Chartmill
Monday's session: most active stocks ↗
Via Chartmill
News headline image
Aspire Biopharma Announces $5.0 Million Share Repurchase Program
Via ACCESS Newswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Top movers in Tuesday's session ↗
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session. ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition
Via ACCESS Newswire
News headline image
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo
Via ACCESS Newswire
News headline image
Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue
Via ACCESS Newswire
News headline image
These stocks are moving in today's session ↗
Curious to know what's happening on the US markets one hour before the close of the markets on Wednesday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Topics Artificial Intelligence
News headline image
Here are the top movers in Wednesday's session. ↗
Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
Topics Artificial Intelligence
News headline image
Wednesday's session: gap up and gap down stocks ↗
The session on Wednesday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
Topics Artificial Intelligence
News headline image
These stocks are moving in today's pre-market session ↗
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
Topics Artificial Intelligence
News headline image
Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Wednesday's session: top gainers and losers ↗
Via Chartmill
News headline image
Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion
Via ACCESS Newswire
News headline image
Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director
Via ACCESS Newswire
News headline image
Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026
Via ACCESS Newswire
News headline image
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.